finanzen.net

AstraZeneca Aktie WKN: 886455 / ISIN: GB0009895292

71,82EUR
-0,03EUR
-0,04%
19.07.2019
758,60SEK
+1,40SEK
+0,18%
19.07.2019
KAUFEN
VERKAUFEN
mehr Daten anzeigen

AstraZeneca News

17.07.19
AstraZeneca to pay millions of pounds to former staff (Financial Times)
15.07.19
AstraZeneca PLC : Update on US regulatory decision for Farxiga (Investegate)
12.07.19
AstraZeneca PLC : Imfinzi granted US Orphan Drug Designation for (Investegate)
11.07.19
AstraZeneca takes lessons from fast food to serve China (Financial Times)
08.07.19
AstraZeneca : Lung Ambition Alliance launches with goal to double five-year survival in lung cancer by 2025 (Investegate)
02.07.19
AstraZeneca Gets CHMP Nod for Forxiga/Fasenra Expanded Label (Zacks)
01.07.19
AstraZeneca PLC : Total Voting Rights (Investegate)
01.07.19
AstraZeneca PLC : Fasenra receives positive EU CHMP opinion for self (Investegate)
01.07.19
AstraZeneca PLC : Forxiga receives positive EU CHMP opinion for (Investegate)
27.06.19
AstraZeneca PLC : Imfinzi improves overall survival at interim (Investegate)
19.06.19
AstraZeneca PLC : Bevespi Aerosphere approved by the Japanese (Investegate)
19.06.19
AstraZeneca PLC : Lynparza approved in Japan for 1st-line (Investegate)
19.06.19
AstraZeneca PLC : Breztri Aerosphere (PT010) approved in Japan for (Investegate)
18.06.19
AstraZeneca PLC : Lynparza approved in the EU for 1st-line (Investegate)
17.06.19
AstraZeneca Gives Detailed Data From Calquence Leukemia Study (Zacks)
17.06.19
AstraZeneca PLC : Calquence significantly prolonged the time patient (Investegate)
10.06.19
AstraZeneca says its lung cancer drug still waiting for approval (Irish Times)
10.06.19
The Zacks Analyst Blog Highlights: Bristol Myers, Merck, Roche, Lilly and AstraZeneca (Zacks)
06.06.19
AstraZeneca PLC : Calquence Phase III ELEVATE-TN trial met primary (Investegate)
05.06.19
Hardman & Co Research: AstraZeneca: Where has all the cash gone? (EQS Group)
05.06.19
Hardman & Co Research : AstraZeneca: Where has all the cash gone? (Investegate)
03.06.19
UPDATE 1-AstraZeneca searches for successor to Chairman Johansson - Sky News (Reuters)
03.06.19
AstraZeneca searches for successor to Chairman Johansson - Sky News (Reuters)
03.06.19
AstraZeneca searches for successor to Chairman Johansson - Sky News (Reuters)
03.06.19
AstraZeneca PLC : Total Voting Rights (Investegate)
03.06.19
AstraZeneca PLC : Block listing Interim Review (Investegate)
02.06.19
AstraZeneca reports positive results in cancer treatment (Financial Times)
29.05.19
Inovio Pharma stock slips as AstraZeneca unit scales back agreement (Market Watch)
10.05.19
AstraZeneca PLC : Pooled analyses of the roxadustat global Phase III (Investegate)
08.05.19
AstraZeneca PLC : Director/PDMR Shareholding (Investegate)
08.05.19
AstraZeneca PLC : Director Declaration (Investegate)
08.05.19
AstraZeneca PLC : Trastuzumab deruxtecan demonstrated clinically (Investegate)
07.05.19
AstraZeneca PLC : Calquence PhIII ASCEND trial met primary endpoint (Investegate)
03.05.19
AstraZeneca PLC : Qternmet XR approved in the US for type-2 diabetes (Investegate)
02.05.19
AstraZeneca ties up with France's Transgene to develop viral immunotherapies (Reuters)
01.05.19
AstraZeneca PLC : Total Voting Rights (Investegate)
01.05.19
AstraZeneca PLC : Director/PDMR Shareholding (Investegate)
29.04.19
Better Big Pharma Stock: AbbVie vs. AstraZeneca (FOX Business)
29.04.19
Better Big Pharma Stock: AbbVie vs. AstraZeneca (MotleyFool)
29.04.19
AstraZeneca PLC : Lynparza receives positive EU CHMP opinion for 1st (Investegate)
Seite: 123456789...20

AstraZeneca News

AstraZeneca News: auf dieser Seite finden Sie alle AstraZeneca News und Nachrichten zur AstraZeneca Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch AstraZeneca News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um AstraZeneca News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.

Online Brokerage über finanzen.net

finanzen.net Brokerage
Handeln Sie für nur 5 Euro Orderprovision* pro Trade aus der Informationswelt von finanzen.net!

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.
Zur klassischen Ansicht wechseln
Kontakt - Impressum - Werben - Pressemehr anzeigen
Top News
Beliebte Suchen
DAX 30
Öl
Euro US-Dollar
Bitcoin
Goldpreis
Meistgesucht
Microsoft Corp.870747
Deutsche Bank AG514000
Wirecard AG747206
Daimler AG710000
Amazon906866
Scout24 AGA12DM8
Apple Inc.865985
TeslaA1CX3T
NEL ASAA0B733
Allianz840400
Infineon AG623100
BMW AG519000
BayerBAY001
SAP SE716460
Airbus SE (ex EADS)938914